SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-294930
Filing Date
2023-12-14
Accepted
2023-12-14 07:51:03
Documents
15
Period of Report
2023-12-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d553734d8k.htm   iXBRL 8-K 34192
2 EX-99.1 d553734dex991.htm EX-99.1 18445
7 GRAPHIC g553734g1214092257748.jpg GRAPHIC 2593
  Complete submission text file 0001193125-23-294930.txt   218120

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pfe-20231214.xsd EX-101.SCH 3869
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pfe-20231214_def.xml EX-101.DEF 13234
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pfe-20231214_lab.xml EX-101.LAB 21858
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pfe-20231214_pre.xml EX-101.PRE 14136
9 EXTRACTED XBRL INSTANCE DOCUMENT d553734d8k_htm.xml XML 5143
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 231485581
SIC: 2834 Pharmaceutical Preparations